Maxcyte (DI) (MXCT)

Index:

FTSE AIM 100

266.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 420.00
  • 52 Week Low: 262.00
  • Currency: UK Pounds
  • Shares Issued: 105.43m
  • Volume: 47,020
  • Market Cap: £280.46m
  • Beta: 0.36

Latest ShareCast News

MaxCyte appoints new chief commercial officer

By Josh White

Date: Thursday 10 Oct 2024

(Sharecast News) - Cell engineering company MaxCyte announced the appointment of Ali Soleymannezhad as its new chief commercial officer on Thursday, effective from 11 September.

MaxCyte enters licence agreement with Kamau Therapeutics

By Josh White

Date: Monday 16 Sep 2024

(Sharecast News) - Cell engineering technology company MaxCyte announced a strategic platform licence agreement with Kamau Therapeutics, a clinical-stage firm specialising in stem cell gene correction therapies, on Monday.

MaxCyte reports solid second-quarter performance

By Josh White

Date: Wednesday 07 Aug 2024

(Sharecast News) - Cell engineering company MaxCyte reported a robust financial performance for its second quarter on Wednesday, with total revenue reaching $10.4m, a 15% increase compared to the same period in 2023.

MaxCyte reports strong first quarter 08-May-2024 ShareCast
MaxCyte reports strong fourth quarter as full-ye... 13-Mar-2024 ShareCast
MaxCyte flags lower 2023 revenue, flat 2024 growth 05-Mar-2024 ShareCast
MaxCyte flags uptick in total fourth-quarter rev... 09-Jan-2024 ShareCast
Maher Masoud starts as MaxCyte president, CEO 02-Jan-2024 ShareCast
MaxCyte announces new CEO, updates revenue guida... 12-Dec-2023 ShareCast
MaxCyte joins Alliance for mRNA Medicines 16-Nov-2023 ShareCast
MaxCyte lowers full-year guidance after weaker t... 05-Oct-2023 ShareCast
MaxCyte signs licence deal with Vittoria Biother... 10-Jul-2023 ShareCast
MaxCyte inks platform licensing deal with Lyell 06-Jul-2023 ShareCast
MaxCyte revises guidance after weaker first quar... 11-May-2023 ShareCast
MaxCyte installs Douglas Swirsky as its new fina... 28-Mar-2023 ShareCast
MaxCyte expecting strong 2023 after decent results 16-Mar-2023 ShareCast
MaxCyte flags 2022 revenue growth, sets new guid... 07-Mar-2023 ShareCast
MaxCyte signs strategic platform licence with Ca... 04-Jan-2023 ShareCast
MaxCyte inks deal with South Korea's Curamys 05-Dec-2022 ShareCast
MaxCyte revenues improve in third quarter 10-Nov-2022 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 266.00p
Change Today 4.00p
% Change 1.53 %
52 Week High 420.00
52 Week Low 262.00
Volume 47,020
Shares Issued 105.43m
Market Cap £280.46m
Beta 0.36

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
17:05 3,000 @ 266.00p
17:05 484 @ 266.00p
16:20 3,000 @ 269.20p
16:19 484 @ 266.50p
16:18 1,460 @ 263.00p

Top of Page